[1]龚泉,王存德,李江龙,等.参芪扶正注射液联合姑息性化疗对晚期结直肠癌疗效的临床观察[J].医学信息,2018,31(01):140-141,144.[doi:10.3969/j.issn.1006-1959.2018.01.054]
 GONG Quan,WANG Cun-de,LI Jiang-long,et al.Clinical Observation on Effect of Shenqi Fuzheng Injection Combined with Palliative Chemotherapy in Patients with Advanced Colorectal Cancer[J].Journal of Medical Information,2018,31(01):140-141,144.[doi:10.3969/j.issn.1006-1959.2018.01.054]
点击复制

参芪扶正注射液联合姑息性化疗对晚期结直肠癌疗效的临床观察()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年01期
页码:
140-141,144
栏目:
中医中药
出版日期:
2018-01-01

文章信息/Info

Title:
Clinical Observation on Effect of Shenqi Fuzheng Injection Combined with Palliative Chemotherapy in Patients with Advanced Colorectal Cancer
文章编号:
1006-1959(2018)01-0140-03
作者:
龚泉王存德李江龙李仕娟石围
昆明医科大学第三附属医院云南省肿瘤医院姑息医学科/云南省肿瘤姑息医学研究中心, 云南昆明650118
Author(s):
GONG QuanWANG Cun-deLI Jiang-longLI Shi-juanSHI Wei
Palliative Medicine,The Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital/Yunnan Palliative Medicine Research Center,Kunming 650118,Yunnan,China
关键词:
参芪扶正注射液姑息性化疗晚期结直肠癌生活质量
Keywords:
Key words:Shenqi Fuzheng injectionPalliative chemotherapyAdvanced colorectal cancerQuality of life
分类号:
R735.3+7
DOI:
10.3969/j.issn.1006-1959.2018.01.054
文献标志码:
A
摘要:
目的观察晚期结直肠癌姑息性化疗中联合应用参芪扶正注射液的疗效遥方法将118 例晚期结直肠癌患者随机分为 治疗组(参芪扶正注射液联合姑息性化疗)61 例和对照组(单纯姑息性化疗组)57 例,对比观察两组患者3 周期姑息性化疗后的 总体有效率尧化疗不良反应和生活质量改善情况遥结果治疗组总有效率77.05%,对照组56.14%,治疗组总有效率明显优于对 照组,两组间差异显著( 约0.05)曰治疗组患者胃肠道反应尧骨髓抑制等不良反应发生率均显著低于对照组( 约0.05)曰患者生存质 量改善情况治疗组(68.85%)优于对照组(49.12%),两组差异有统计学意义( 约0.05)遥结论晚期结直肠癌患者姑息性化疗联合 应用参芪扶正注射液,能够取得较好疗效,同时减轻化疗不良反应尧改善生活质量
Abstract:
Abstract:Objective To observe the curative effect of advanced colorectal cancer palliative chemotherapy combined application of Shenqi Fuzheng injection.Methods 118 patients with advanced colorectal cancer were randomly divided into treatment group(Shenqi Fuzheng injection combined with palliative chemotherapy)in 61 cases and control group (simple palliative chemotherapy group)57 cases,comparison of two groups of patients with total 3 cycles of palliative chemotherapy after the efficacy and adverse reaction of chemotherapy and improve the quality of life.Results The total effective rate was 77.05% in treatment group and 56.14% in the control group,the total effective rate of treatment group was significantly better than the control group,the difference between the two groups was significant ( <0.05);the treatment group patients with gastrointestinal reaction the adverse reaction, bone marrow suppression rate were significantly lower than control group ( <0.05);improve the quality of life of patients with the treatment group (68.85%)better than the control group (49.12%),there was significant difference between two groups ( <0.05).Conclusion The combination of palliative chemotherapy for advanced colorectal cancer patients with Shenqi Fuzheng injection can achieve better curative effect,reduce the adverse reaction of chemotherapy and improve the quality of life

参考文献/References:

[1]Zheng R,Zeng H,Zhang S,et al.National estimates of cancer prevalence in China,2011[J].Cancer Lett,2016,370(1):33-38.
[2]中华人民共和国卫生和计划生育委员会医政医管局.结直肠癌 诊疗规范(2015年版)[J].中国实用外科杂志,2015,53(11):881-894.
[3]AJCC Cancer Staging Handbook:From the AJCC Cancer Staging Manual,7thEdition (2010) [M].Springer -Verlag New York Inc,2010.
[4]王存德,龚泉,张利娟.恶性肿瘤姑息治疗的进展[J].中国肿 瘤,2012,21(3):206-210.
[5]蒋淳琪,沈洁如,刘文奇,等.参芪扶正注射液对结肠癌术后 化疗患者的免疫功能影响[J].黑龙江中医药,2015,44(2):41-42.
[6]谭光根,刘丽,李静,等.参芪扶正注射液对晚期结肠癌临床 疗效及免疫功能影响[J].海南医学院学报,2013,19(5):627-629.
[7]燕飞,周雍明,简鹏.参芪扶正注射液联合化疗对结肠癌患者术 后机体免疫功能的影响[J].中国现代医学杂志,2014,24(16):72-74.
[8]宋默,席姗姗,刘继攀,等.参芪扶正注射液对直肠癌术后化疗患 者免疫功能及化疗毒副作用的影响[J].中医药导报,2015(2):46-48.
[9]邹劲林,李振东,叶友强,等.参芪扶正注射液联合FOLFOX4 对域/芋期大肠癌患者免疫功能和生活质量的影响[J].中国现 代应用药学,2012,29(8):755-758.

相似文献/References:

[1]王 平,苏志红.参芪扶正注射液辅助治疗晚期胃癌的效果[J].医学信息,2019,32(24):50.[doi:10.3969/j.issn.1006-1959.2019.24.016]
 WANG Ping,SU Zhi-hong.Effect of Shenqi Fuzheng Injection on Adjuvant Treatment of Advanced Gastric Cancer[J].Journal of Medical Information,2019,32(01):50.[doi:10.3969/j.issn.1006-1959.2019.24.016]

更新日期/Last Update: 2018-01-22